Published in Diabetes Care on January 01, 2006
Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors | NCT00607139
Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J Pediatr (2009) 3.48
Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes. Diabetes Care (2010) 2.99
Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care (2006) 2.02
Blunted counterregulatory hormone responses to hypoglycemia in young children and adolescents with well-controlled type 1 diabetes. Diabetes Care (2009) 2.01
What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review. Diabetologia (2011) 1.67
Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry. Pediatr Diabetes (2013) 1.54
Impaired overnight counterregulatory hormone responses to spontaneous hypoglycemia in children with type 1 diabetes. Pediatr Diabetes (2007) 1.38
Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am (2010) 1.07
The Impact of Accelerometer and Heart Rate Data on Hypoglycemia Mitigation in Type 1 Diabetes. J Diabetes Sci Technol (2014) 1.00
Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial. Diabetol Metab Syndr (2010) 0.93
The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes. J Diabetes Sci Technol (2014) 0.88
Exercise and the Development of the Artificial Pancreas: One of the More Difficult Series of Hurdles. J Diabetes Sci Technol (2015) 0.84
Prevention of exercise-associated dysglycemia: a case study-based approach. Diabetes Spectr (2015) 0.84
Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation. J Diabetes Sci Technol (2013) 0.82
Relative accuracy of the BD Logic and FreeStyle blood glucose meters. Diabetes Technol Ther (2007) 0.82
Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy. Diabetes Obes Metab (2016) 0.81
Past, present, and future of insulin pump therapy: better shot at diabetes control. Mt Sinai J Med (2008) 0.80
Diabetes research in children network:availability of protocol data sets. J Diabetes Sci Technol (2007) 0.78
Intense exercise in type 1 diabetes: exploring the role of continuous glucose monitoring. J Diabetes Sci Technol (2007) 0.78
Organ-based response to exercise in type 1 diabetes. ISRN Endocrinol (2012) 0.77
Effects of glutamine on glycemic control during and after exercise in adolescents with type 1 diabetes: a pilot study. Diabetes Care (2010) 0.76
Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy. J Diabetes Sci Technol (2015) 0.75
Hypoglycemia during moderate intensity exercise reduces counterregulatory responses to subsequent hypoglycemia. Physiol Rep (2016) 0.75
Key Points from the Updated Guidelines on Exercise and Diabetes. Front Endocrinol (Lausanne) (2017) 0.75
The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion. Diabetes Technol Ther (2017) 0.75
Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care (2005) 8.80
Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974). Clin Chem (1977) 3.31
Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr (2005) 2.83
A multicenter study of the accuracy of the One Touch Ultra home glucose meter in children with type 1 diabetes. Diabetes Technol Ther (2003) 2.23
Type of activity: resistance, aerobic and leisure versus occupational physical activity. Med Sci Sports Exerc (2001) 2.18
The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes Care (2005) 1.61
Intermittent high-intensity exercise does not increase the risk of early postexercise hypoglycemia in individuals with type 1 diabetes. Diabetes Care (2005) 1.32
Independent effects of youth and poor diabetes control on responses to hypoglycemia in children. Diabetes (1991) 1.22
Normalization of the growth hormone and catecholamine response to exercise in juvenile-onset diabetic subjects treated with a portable insulin infusion pump. Diabetes (1979) 0.99
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med (2008) 17.19
Obesity and the metabolic syndrome in children and adolescents. N Engl J Med (2004) 13.99
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med (2002) 11.32
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med (2010) 8.69
Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med (2011) 7.42
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care (2008) 6.53
Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet (2010) 6.50
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79
Calibration of accelerometer output for children. Med Sci Sports Exerc (2005) 5.46
A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol (2003) 5.27
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care (2009) 4.93
A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology (2003) 4.88
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes (2004) 4.44
Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol (2005) 4.38
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15
Effects of a weight management program on body composition and metabolic parameters in overweight children: a randomized controlled trial. JAMA (2007) 4.09
Nephropathy in diabetes. Diabetes Care (2004) 4.08
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology (2007) 3.85
Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther (2008) 3.82
A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology (2007) 3.49
A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology (2004) 3.48
The T1D Exchange clinic registry. J Clin Endocrinol Metab (2012) 3.45
Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol (2005) 3.42
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ (2011) 3.36
Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet (2003) 3.31
A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab (2003) 3.25
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med (2011) 3.20
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Arch Ophthalmol (2007) 3.18
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol (2003) 3.13
Effects of behavioral family systems therapy for diabetes on adolescents' family relationships, treatment adherence, and metabolic control. J Pediatr Psychol (2006) 3.12
Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol (2006) 3.12
Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network. Diabetes Care (2004) 3.11
The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care (2007) 3.11
Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology (2007) 3.08
Continuous glucose monitoring in children with type 1 diabetes. J Pediatr (2007) 3.06
Panretinal photocoagulation for proliferative diabetic retinopathy. N Engl J Med (2011) 2.98
Response to nocturnal alarms using a real-time glucose sensor. Diabetes Technol Ther (2005) 2.98
Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation (2002) 2.93
Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology (2006) 2.89
Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. Diabetes Care (2009) 2.85
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP). Diabetes Technol Ther (2013) 2.85
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol (2009) 2.84
Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr (2005) 2.83
Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care (2013) 2.73
Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab (2010) 2.70
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis (2003) 2.68
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology (2012) 2.68
Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med (2005) 2.67
Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes (2005) 2.64